Perspective Therapeutics Cash Flow Statement (2010-2026) | CATX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
0.36M-2.59M-1.60M-1.35M-3.42M-7.49M-2.27M-1.47M-1.62M-0.78M-5.18M-0.46M-0.49M0.51M-28.93M
Depreciation and Depletion (Quarter)
0.06M-0.08M0.06M0.13M0.20M0.14M0.18M0.24M0.26M-0.45M0.35M0.57M0.67M-1.58M
Share-based Compensation (Quarter)
0.52M0.60M0.18M0.16M0.31M0.78M0.50M0.98M1.05M0.42M0.12M0.66M0.59M1.95M2.06M2.10M2.40M2.16M2.31M2.55M
Deferred Taxes (Quarter)
-10.50M7.85M-2.10M
Asset Writedowns and Impairment (Quarter)
0.30M0.30M0.33M0.04M10.00M
Change in Interest Receivables (Quarter)
0.88M0.07M0.21M0.02M-0.16M0.39M
Cash from Operations (Quarter)
-2.08M2.68M-1.42M-4.32M-6.08M-6.09M-9.72M-8.07M-10.11M-9.01M13.85M-8.90M3.37M-26.61M-21.58M-19.95M-16.29M-24.66M-31.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.01M-0.01M0.01M0.02M0.03M0.02M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF) (Quarter)
0.06M-0.08M0.07M0.15M0.20M0.14M0.19M0.26M0.26M0.30M0.36M0.57M0.67M0.71M0.73M0.73M0.78M1.01M1.13M
Change in Working Capital
Change in Receivables (Quarter)
-0.11M0.07M0.49M-0.04M-0.43M-0.24M0.00M-0.25M0.62M-0.57M-0.17M-0.81M0.15M-0.22M-0.04M0.15M-0.05M-0.17M0.05M
Change in Inventory (Quarter)
0.80M-1.26M-0.08M1.92M2.02M0.08M-0.13M-0.02M-0.11M-0.10M-0.03M0.02M
Change in Accured Expenses (Quarter)
0.04M-1.64M-0.08M0.02M1.65M0.57M-0.59M1.03M-1.12M2.26M-0.88M-0.40M1.67M3.21M-2.57M-1.98M5.54M1.02M-3.61M
Other Working Capital Changes (Quarter)
0.06M0.09M0.14M0.06M0.04M0.05M
Investing Activities
Capital Expenditures (Quarter)
0.05M-0.09M0.03M0.13M0.22M0.15M0.20M0.56M0.23M0.09M10.09M29.71M14.61M4.66M-4.61M0.04M12.66M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
2.70M
Change in Acquisitions & Divestments (Quarter)
12.54M22.76M78.73M21.70M-21.70M173.95M47.64M
Cash from Investing Activities (Quarter)
-0.05M35.18M-0.03M-0.15M-35.31M-28.84M25.26M-0.57M-0.23M-0.09M-47.30M-3.29M-29.74M-138.60M-5.57M4.26M13.99M28.54M-109.55M
Financing Activities
Other financing activities (Quarter)
0.03M-0.23M0.03M0.03M0.53M-0.53M0.13M-0.00M0.77M0.36M0.37M-0.37M0.29M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.01M0.02M0.02M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Capital Stock
Shares Issued (Quarter)
4.51M7.33M7.27M4.04M6.91M5.95M10.81M37.87M44.87M44.68M5.11M7.35M5.44M
Net Equity Issued and Repurchased (Quarter)
-56.38M0.40M
Misc.
Cash from Financing Activities (Quarter)
0.03M0.03M0.03M-0.08M0.51M0.00M0.35M166.33M122.08M0.63M0.34M9.97M0.13M0.21M-0.01M164.36M
Change in Cash (Quarter)
-2.14M37.89M-1.45M-4.46M-41.37M-34.90M15.46M-8.13M-10.34M-8.74M132.88M109.89M-25.74M-164.86M-17.17M-15.56M-2.09M3.87M23.34M
Free Cash Flow (Quarter)
-2.14M2.77M-1.45M-4.45M-6.30M-6.24M-9.92M-8.63M-10.34M-9.10M13.85M-18.99M-26.35M-41.22M-26.24M-15.34M-16.33M-37.32M-31.47M
Net Cash Flow (Quarter)
-2.14M37.89M-1.45M-4.46M-41.37M-34.90M15.46M-8.13M-10.34M-8.74M132.88M109.89M-25.74M-164.86M-17.17M-15.56M-2.09M3.87M23.34M